John Newman, Ph.D.Canaccord Genuity
Keay NakaeChardan Capital Markets
Joseph Thome, Ph.D.Cowen
Chris ShibutaniGoldman Sachs
Tessa RomeroJP Morgan
Jeff Jones, Ph.D.Oppenheimer
Edward A. TenthoffPiper Sandler
Seres Therapeutics is followed by the analysts listed. Please note that any opinions, estimates or forecasts regarding Seres Therapeutics's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Seres Therapeutics or its management. Seres Therapeutics does not by its reference or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.